CIK 0001699350
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SHOULDER INNOVATIONS, INC.
Sign in to watch- Ticker
- SI
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270538764
- Phone
- +1 616-294-1026
- Business address
- 1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS, MI, 49507
- 4 Option exercise Chief Operating Officer acquired 21,664 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $15.00 ($30,000)
- 4 Shares withheld for taxes Director gave up 7,006 shares (to pay taxes)
- 4 Open-market buy Director bought 1,000 shares at $14.84 ($14,840)
- 4 Open-market buy CEO & Executive Chairman bought 2,200 shares at $15.18 ($33,392)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise CEO & Executive Chairman acquired 12,062 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 1,076 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,041 shares (grant or award)
- 4 Grant or award CEO & Executive Chairman acquired 1,661 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 477 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $14.82 ($29,632)
- 4 Open-market buy CEO & Executive Chairman bought 7,200 shares at an average $14.86 ($107,009)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 1,600 shares at $15.67 ($25,072)
- 4 Option exercise SEE REMARKS acquired 94,394 shares (option exercise)
- 4 Open-market buy CEO & EXECUTIVE CHAIRMAN bought 8,000 shares at an average $15.34 ($122,755)
Page 2 of 4 · 65 filings